India, with its diverse climatic conditions and high population density, presents a significant burden of vector-borne diseases (VBDs). These diseases, transmitted by vectors such as mosquitoes, ticks, and flies, pose substantial challenges to the public health system.
India is endemic to several VBDs, including malaria, dengue, chikungunya, and Japanese encephalitis. Despite concerted efforts, India accounts for 4% of global malaria cases. Dengue cases have shown an alarming rise, with a 300% increase in the past decade. Chikungunya and Japanese encephalitis also persistently contribute to the disease burden.
VBDs cause significant morbidity and mortality, straining India's healthcare system. They disrupt socio-economic development and pose a substantial threat to the achievement of the Sustainable Development Goals. The economic burden of these diseases is immense, with an estimated annual cost of USD 1.34 billion for malaria alone.
India's fight against VBDs is marred by inadequate surveillance, limited resources, and climate change. However, opportunities exist in the form of improved diagnostic tools, vector control strategies, and vaccines. The recent launch of the National Vector Borne Disease Control Programme (NVBDCP) signifies a step in the right direction.
Vector-borne diseases remain a significant public health challenge in India, necessitating a comprehensive, multi-pronged approach. There is a pressing need for improved surveillance, early diagnosis, effective management, and preventive measures. As healthcare professionals, our role extends beyond clinical management to advocacy, research, and education, contributing to a robust response against VBDs.
1.
Toxic fungus from King Tutankhamun's tomb yields cancer-fighting compounds—new study
2.
Study shows virtual reality headsets may help ease cancer pain
3.
Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer
4.
Spouses of Cancer Patients May Be at Increased Risk of Suicide
5.
Study finds 81% of cancer cures touted by TikTok videos are fake
1.
Personalized Survivorship Navigation in Precision Cancer Care
2.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
3.
Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy
4.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
5.
Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Nutrition Can Support Patients During Cancer Care
2.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
3.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
5.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation